Immunohistochemistry analysis using anti‐programmed death‐ligand 1 (PD‐L1) antibody (clone 28‐8) showed that PD‐L1 was expressed 25% in tumor positive score (TPS), 20% in immune cells (IC), and 40 in combined positive score (CPS) (Figure 2B). The gene discussed is CD274; the disease is neoplasm.